Abbott Laboratories

Healthcare · Medical Devices

101.30$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Abbott Laboratories (ABT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 86,713 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABT
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	11,126	12,061	13,216	14,471	15,283	23,296	24,259	26,715	28,767	29,141	36,178	39,714	42,419	52,582	60,574	60,277	67,235	42,953	43,791	44,001	55,011	76,250	67,173	67,887	72,548	75,196	74,438	73,214	81,414	86,713
Current Assets	4,481	5,038	5,553	6,420	7,376	8,419	9,122	10,290	10,734	11,386	11,282	14,043	17,043	23,314	22,318	23,769	31,323	19,247	15,261	14,155	26,776	20,147	14,632	15,667	20,441	24,239	25,224	22,670	23,656	25,996
Cash	110	230	308	608	914	657	704	995	2,059	2,894	521	2,456	4,112	8,809	7,324	6,813	10,802	3,475	4,063	5,001	18,620	9,407	3,844	3,860	6,838	9,799	9,882	6,896	7,616	8,522
Cash & Short-Term Investments	123	259	383	723	1,157	714	966	1,286	2,059	2,956	1,373	2,821	5,080	9,932	7,324	8,097	15,174	8,098	4,460	6,125	18,775	9,610	4,086	4,140	7,148	10,249	10,170	7,279	7,967	8,939
Receivables	1,709	1,782	1,956	2,056	2,179	2,813	2,927	3,313	3,696	3,577	4,231	4,947	5,466	6,542	7,184	7,684	7,613	3,986	3,586	3,418	3,248	5,249	5,182	5,425	6,414	6,487	6,218	6,565	6,925	7,929
Inventory	1,238	1,280	1,411	1,495	1,741	2,212	2,441	2,738	2,620	2,542	2,806	2,951	2,776	3,265	3,189	3,284	3,793	2,693	2,643	2,599	2,434	3,601	3,796	4,316	5,012	5,157	6,173	6,570	6,194	6,488
Property, Plant & Equipment	–	–	–	–	4,817	5,552	5,828	6,282	6,008	6,003	6,946	7,518	7,219	7,619	7,971	7,874	8,063	5,905	5,935	5,730	5,705	7,607	7,563	8,038	9,029	8,959	9,162	11,276	11,733	12,942
Goodwill	–	–	–	–	–	–	3,733	4,449	5,685	5,219	9,449	10,129	9,987	13,200	15,930	15,705	15,774	9,772	10,067	9,638	7,683	24,020	23,254	23,195	23,744	23,231	22,799	23,679	23,108	24,035
Intangible Assets	980	1,112	1,350	1,575	1,555	7,294	7,652	8,539	5,172	4,742	6,404	5,720	5,151	6,292	12,152	9,990	8,588	5,735	6,198	5,562	4,539	21,473	18,942	17,025	14,784	12,739	10,454	8,815	6,647	5,526
Total Liabilities	6,305	7,062	7,503	7,043	6,712	14,237	13,595	13,643	14,442	14,726	22,124	21,935	24,940	29,518	36,986	35,751	40,422	17,686	19,636	19,921	31,949	45,152	36,451	36,586	39,545	39,172	37,533	34,387	33,513	33,942
Current Liabilities	4,344	5,034	4,962	4,517	4,298	7,927	7,002	7,640	6,826	7,416	11,951	9,103	11,592	13,049	17,262	15,480	13,280	9,507	10,532	9,186	6,660	8,912	9,012	10,863	11,907	13,105	15,489	13,841	14,157	16,496
Short-Term Debt	1,384	1,781	1,759	896	479	2,953	2,149	2,537	1,993	2,062	5,401	2,726	2,732	5,190	6,395	3,375	2,391	3,173	4,437	3,130	1,325	714	207	1,683	461	999	2,481	1,325	1,754	3,309
Accounts Payable	923	1,001	1,057	1,227	1,356	1,525	1,662	1,078	1,054	1,033	1,176	1,220	1,351	1,281	1,536	1,721	1,797	1,026	1,064	1,081	1,178	2,402	2,975	3,252	3,946	4,408	4,607	4,295	4,195	4,240
Long-Term Debt	–	–	–	–	1,076	4,335	4,274	3,452	4,788	4,572	7,010	9,488	8,713	11,266	12,524	12,040	18,085	3,388	3,408	5,871	20,681	27,210	19,359	16,661	18,527	17,296	14,522	13,599	12,625	9,896
Shareholders' Equity	4,820	4,999	5,714	7,428	8,571	9,059	10,665	13,072	14,326	14,415	14,054	17,779	17,480	23,144	22,677	24,440	26,721	25,171	21,526	21,211	20,538	30,897	30,524	31,088	32,784	35,802	36,686	38,603	47,664	52,130
Retained Earnings	4,263	4,428	4,555	6,174	7,230	7,281	8,601	9,691	10,033	10,405	9,569	10,806	13,825	17,054	18,927	20,907	24,151	21,979	22,874	25,757	25,565	23,978	24,560	25,847	27,627	31,528	35,257	37,554	47,261	49,781
Shares Outstanding	1,582	1,575	1,561	1,558	1,566	1,566	1,573	1,572	1,571	1,564	1,537	1,560	1,561	1,555	1,556	1,570	1,592	1,574	1,527	1,506	1,483	1,749	1,770	1,781	1,786	1,789	1,764	1,749	1,748	1,747

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings